JP Morgan Chase
NARI

JP Morgan Chase’s Inari Medical, Inc. Common Stock NARI Stock Holding History

JP Morgan Chase’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-896,786
Closed -$45.8M – 7858
2024
Q4 		$45.8M Sell
896,786
-226,816
-20% -$11.1M ﹤0.01% 1384
2024
Q3 		$46.3M Sell
1,123,602
-47,878
-4% -$2.3M ﹤0.01% 1378
2024
Q2 		$56.4M Buy
1,171,480
+30,767
+3% +$1.36M ﹤0.01% 1185
2024
Q1 		$54.7M Sell
1,140,713
-504,422
-31% -$26.9M ﹤0.01% 1235
2023
Q4 		$107M Buy
1,645,135
+290,759
+21% +$17.5M 0.01% 848
2023
Q3 		$88.6M Buy
1,354,376
+279,435
+26% +$17.6M 0.01% 859
2023
Q2 		$62.5M Buy
1,074,941
+725,796
+208% +$45.8M 0.01% 1022
2023
Q1 		$21.6M Buy
349,145
+33,597
+11% +$2.02M ﹤0.01% 1609
2022
Q4 		$20.1M Buy
315,548
+197,577
+167% +$14.3M ﹤0.01% 1678
2022
Q3 		$8.57M Buy
117,971
+19,338
+20% +$1.44M ﹤0.01% 2284
2022
Q2 		$6.71M Sell
98,633
-256,965
-72% -$18.5M ﹤0.01% 2514
2022
Q1 		$32.2M Sell
355,598
-27,939
-7% -$2.29M ﹤0.01% 1419
2021
Q4 		$35M Sell
383,537
-5,703
-1% -$489K ﹤0.01% 1405
2021
Q3 		$31.6M Buy
389,240
+354,264
+1,013% +$29.8M ﹤0.01% 1441
2021
Q2 		$3.26M Sell
34,976
-227,762
-87% -$22.1M ﹤0.01% 3402
2021
Q1 		$28.1M Buy
262,738
+234,597
+834% +$24.3M ﹤0.01% 1477
2020
Q4 		$2.46M Buy
28,141
+25,275
+882% +$1.79M ﹤0.01% 3338
2020
Q3 		$198K Buy
+2,866
New +$184K ﹤0.01% 4368

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

JP Morgan Chase's NARI Position: Q1 2025 in Review

JP Morgan Chase sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 896,786 shares — an estimated $45.8M sold.

JP Morgan Chase first reported a position in NARI in Q3 2020 and held it in 18 quarters. The position peaked at $107M in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • JP Morgan Chase reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 896,786 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $45.8M.
  • JP Morgan Chase first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
  • JP Morgan Chase's Inari Medical, Inc. Common Stock position peaked at $107M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.